-
Founded in:
1999-12-01 -
Country:
China -
Address:
No. 19, Xinye 9th Street, West District, Tianjin Development Zone -
Tax NO.:
9112000071824811X4 -
Registered Funds:
1,091.88668 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Hydrocortisone |
Adrenal cortex hormone drugs. Superphysiological doses of glucocorticoids have multiple pharmacological effects such as anti-inflammatory, anti-allergic and immunosuppressive. 1 Anti-inflammatory effect: glucocorticoids reduce and prevent tissue response to inflammation, thereby reducing the manifestation of inflammation. 2 Immunosuppressive effect: prevent or inhibit cell-mediated immune response, delayed allergic reaction, and reduce the expansion of primary immune response. 3 Anti-toxic and anti-shock effects: glucocorticoids can counteract the stimulation of bacterial endotoxins on the body, reduce cell damage, and play a role in protecting the body.
More
Adrenal cortex hormone drugs. Superphysiological doses of glucocorticoids have multiple pharmacological effects such as anti-inflammatory, anti-allergic and immunosuppressive. 1 Anti-inflammatory effect: glucocorticoids reduce and prevent tissue response to inflammation, thereby reducing the manifestation of inflammation. 2 Immunosuppressive effect: prevent or inhibit cell-mediated immune response, delayed allergic reaction, and reduce the expansion of primary immune response. 3 Anti-toxic and anti-shock effects: glucocorticoids can counteract the stimulation of bacterial endotoxins on the body, reduce cell damage, and play a role in protecting the body. |
50-23-7 | 26 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L-Lysine acetate |
Unspecified
More
Unspecified |
57282-49-2 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| DL-Serine |
|
302-84-1 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L(+)-Arginine |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
74-79-3 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| N-[(tert-Butoxy)carbonyl]-D-tryptophan |
Extract from the above information
More
Extract from the above information |
0 |